11. Pediatrics Flashcards
ontogeny
development
need a fundamental understanding of the role of ontogeny in the disposition and action of drugs
neonate
birth to less than 1 month
term neonate: born at a gestational age of at least 37 weeks
premature neonate: born at a gestational age of less than 37 weeks
infant
1 month to less than 1 year
child
1-12 years
adolescent
13-18 years
limited data on drug safety and efficacy
20-40% of drugs have FDA approved labeling, most drugs used off label for children
do not have sufficent research due to:
ethical issues difficulties recruiting challenges with consent/assent(children give OK) not as profitable need for pediatric infastructure
Pharmacokinetics
what body does to drug: different in kids
GI absorption
slower gastric emptying in neonates/infants:
therapeutic effects may be delayed
more efficient absorption
higher gastric pH in neonates/infants due to immature acid secretion
higher plasma concentration of acid-labile drugs(penicillin)
will not break down as readily - more drug makes it to the small intestine
skin absorption
percutaneous drug absorption is increased in children (especially neonates/infants) due to:
thinner epidermal barrier (stratum corneum)
increased skin perfusion - increased vasculature to skin
ratio of total body surface area to body mass is increased - amount of drug that is absorbed is increased
volume of distribution (Vd)
in neonates/infants extracellular and total body water is increased- sacks of water
larger Vd for water-soluble drugs-need for higher dose per unit of body weight to reach therapeutic plasma concentration
Plasma protein binding
noenates and infants exhibit decreased plama protein concentration, decreased protein binding capacity and decreased affinity for drug
increase in free fraction of drug - increase pharmacological and adverse drug effects
albumin has lower capacity or afiinity to bind to drugs = increae free fraction of drugs available for action
ceftriaxone
can cause kernicterus in neonates
highly protein bound to albuminn in noepnates so displaces bilirubin (endogenous substance)
with excess bilirubin it will cross BBB and cause irreversible neurological damage
drug metabolism
slower in noenates and infants compared to other children and adults - takes time for metabolizing enzymes to mature
drug metabolism is faster in pre-pubertal children compared to post-pubertal children and adults
renal excretion
process of glomerular filtration and tubular reabsorption and secretion may not fully develop until 1-2 years after birth
neonates and infatnts require lower doses of renally eleminated drugs
premature neonates have signifcantly reduced renal function
young children have increased renal function compared to older children and adults - Creatinine clearance declines over time
pharmacodynamic differences in childre
what body does to drug
not as well studied or understood as PK differences
maturational changes in receptor conformation, density, affinity and signal transduction